Related Experiment Video
Updated: Oct 17, 2025

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
Published on: November 27, 2016
Ileal mucosa-associated microbiota overgrowth associated with pathogenesis of primary biliary cholangitis
Shogo Kitahata1, Yasunori Yamamoto2, Osamu Yoshida1
1Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, 791-0295, Japan.
Abstract:
The small intestinal mucosa-associated microbiota (MAM) can potentially impact the etiology of primary biliary cholangitis (PBC). Herein, we investigate the MAM profile to determine its association with liver pathology in patients with PBC. Thirty-four patients with PBC and 21 healthy controls who underwent colonoscopy at our hospital were enrolled in our study. We performed 16S ribosomal RNA gene sequencing of MAM samples obtained from the mucosa of the terminal ileum and examined the relationship between the abundance of ileal MAM and chronic nonsuppurative destructive cholangitis using liver specimens from patients with PBC. There was a significant reduction in microbial diversity within individuals with PBC (P = 0.039). Dysbiosis of ileal MAM was observed in patients with PBC, with a characteristic overgrowth of Sphingomonadaceae and Pseudomonas. Multivariate analysis showed that the overgrowth of Sphingomonadaceae and Pseudomonas is an independent association factor for PBC (P = 0.0429, P = 0.026). Moreover, the abundance of Sphingomonadaceae was associated with chronic nonsuppurative destructive cholangitis in PBC (P = 0.00981). The overgrowth of Sphingomonadaceae and Pseudomonas in ileal MAM was found in patients with PBC. Sphingomonadaceae may be associated with the pathological development of PBC.
Insights
Patients with primary biliary cholangitis (PBC) show altered gut bacteria in the small intestine. Specific bacteria, Sphingomonadaceae and Pseudomonas, were found to be overgrown and linked to liver damage in PBC.
Area of Science:
- Gastroenterology
- Microbiology
- Immunology
Background:
- Primary biliary cholangitis (PBC) is a chronic liver disease with an autoimmune component.
- The role of the small intestinal mucosa-associated microbiota (MAM) in PBC pathogenesis is not fully understood.
Purpose of the Study:
- To investigate the association between the ileal MAM profile and liver pathology in patients with PBC.
- To identify specific microbial alterations in PBC patients.
Main Methods:
- 16S ribosomal RNA gene sequencing was performed on MAM samples from the terminal ileum of 34 PBC patients and 21 healthy controls.
- Ileal MAM composition was correlated with histological findings of chronic nonsuppurative destructive cholangitis in PBC liver specimens.
Main Results:
- PBC patients exhibited reduced microbial diversity in the ileal MAM.
- A significant dysbiosis was observed, characterized by the overgrowth of Sphingomonadaceae and Pseudomonas in PBC patients.
- Overgrowth of Sphingomonadaceae and Pseudomonas were independent risk factors for PBC.
- Sphingomonadaceae abundance was significantly associated with the severity of chronic nonsuppurative destructive cholangitis.
Conclusions:
- Ileal MAM dysbiosis, particularly the overgrowth of Sphingomonadaceae and Pseudomonas, is characteristic of PBC.
- Sphingomonadaceae may play a role in the pathological development of PBC.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...

